Mode
Text Size
Log in / Sign up
N/A Completed N=40 Randomized Double-blind Basic Science

CUSTOM-DBS: Current Steering to Optimize Deep Brain Stimulation

Source: ClinicalTrials.gov NCT01896115 ↗
Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Feb 2017
Primary outcomePrimary: Therapeutic Window — 3.81; 2.32 mA

Summary

The objective of the study is to compare different deep brain stimulation (DBS) settings using the commercially approved Boston Scientific Neuromodulation Vercise system.

Outcome Measures

OutcomeResultp-value
PRIMARY
Therapeutic Window
3.81; 2.32 —
PRIMARY
Unified Parkinson's Disease Rating Scale III
31.9; 31.3 —
SECONDARY
Side Effect Thresholds - Single Contact vs. Steering
5.3; 5.2 —
SECONDARY
Resting Tremor Severity - Single Contact vs. Steering
0.2; 0.2 —
SECONDARY
Finger Tapping Amplitude - Single Contact vs. Steering
2.2; 2.3 —

Eligibility Criteria

Inclusion Criteria

  • Implanted bilaterally in STN with a Vercise DBS system for Parkinson's disease for at least three months with programming optimized according to standard of care.
  • UPDRS subset III score of ≥30 in the in the pre-operative meds off state.
  • DBS must improve PD symptoms by ≥30% in the meds off state, as measured by UPDRS subset III score.
  • Medical and mental fitness to comply with programming visit and study related procedures.
  • Able to understand the study requirements and the treatment procedures and provides written informed consent before any study-specific tests or procedures are performed.
  • Off symptom rigidity score of ≥2 in the evaluated arm as determined by the UPDRS-III.

Exclusion Criteria

  • Have any significant medical condition that is likely to interfere with study procedures or likely to confound evaluation of study endpoints, including any terminal illness with survival <12 months.
  • Resting and/or action tremor score of ≥3 on the evaluated side as determined by the UPDRS-III in pre-operative meds off condition.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01896115). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search